[1]苏显都a,范长玲a,于 莉a,等.琼西地区精神分裂症患者血浆MiR-137,MiR-181b及MiR-132表达及其相关性研究[J].现代检验医学杂志,2016,31(04):30-34.[doi:10.3969/j.issn.16717-414.2016.04.007]
　SU Xian-dua,FAN Chang-linga,YU Lia,et al.Expression of Plasma MiR-137,MiR-181b and MiR-132 of Schizophrenia Patients in Qiongxi Area and Its Correlation Study[J].Journal of Modern Laboratory Medicine,2016,31(04):30-34.[doi:10.3969/j.issn.16717-414.2016.04.007]
点击复制

琼西地区精神分裂症患者血浆MiR-137,MiR-181b及MiR-132表达及其相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第31卷
期数:
2016年04期
页码:
30-34
栏目:
论著
出版日期:
2016-08-10

文章信息/Info

Title:
Expression of Plasma MiR-137,MiR-181b and MiR-132 of Schizophrenia Patients in Qiongxi Area and Its Correlation Study
文章编号:
1671-7414(2016)04-030-05
作者:
苏显都a; 范长玲a; 于 莉a; 李德芬b; 谢晋军b; 张素领a; 张小华a; 黄钰花b
海南省农垦那大医院a.检验科;
b.精神科,海南那大 571799
Author(s):
SU Xian-dua; FAN Chang-linga; YU Lia; LI De-fenb; XIE Jin-junb; ZHANG Su-linga;  ZHANG Xiao-huaa; HUANG Yu-huab
a.Department of Clinical Laboratory;
b.Department of Psychiatry,Nongken Nada's Hospital,Hainan Nada 571799,China
关键词:
琼西地区;  精神分裂症;  microRNA
分类号:
R749.3; R392.11
DOI:
10.3969/j.issn.16717-414.2016.04.007
文献标志码:
A
摘要:
目的 探讨microRNA-137(MiR-137),microRNA-181b(MiR-181b)及microRNA-132(MiR-132)表达水平在琼西地区精神分裂症患者抗精神病药物治疗过程的变化及相关性。方法 选取琼西地区386例精神分裂症患者(病例组)和106例健康体检者(对照组),采用实时荧光定量PCR检测两组血浆MiR-137,MiR-181b及MiR-132表达水平。在病例组中选阳性与阴性症状量表(PANSS)分>70分的104例患者(观察组),于治疗前、治疗14天、治疗30天、治疗50天分别检测MiR-137,MiR-181b及MiR-132表达水平,并采用PANSS,大体评定量表(GAS)和病情严重程度量表(SI)对不同治疗阶段的临床症状及疗效进行评估。结果 与对照组比较,病例组MiR-181b及MiR-132表达水平显著上调(Z=-3.315,P=0.001; Z=-2.036,P=0.038)。观察组治疗30天和50天血浆MiR-181b及MiR-132表达水平较治疗前及治疗14天显著下调(t=8.382～12.651,P<0.05),且观察组治疗50天血浆MiR-181b及MiR-132表达水平较治疗30天显著下调(t=7.695～12.824,P<0.05)。随着治疗时间延长观察组患者PANSS评分及SI评分显著降低(t=8.711～10.273,P<0.01),而随着治疗时间延长观察组患者GAS评分显著增高(t=7.523～12.861,P<0.01)。相关分析显示,与治疗30天比较,治疗50天病例组MiR-181b及MiR-132表达水平下调与GAS评分呈明显正相关(r=0.537,P<0.05; r=0.492,P<0.05); 治疗50d与治疗前比较,病例组MiR-181b及MiR-132表达水平的下调与PANSS评分呈明显负相关(r=-0.503,P<0.05; r=-0.516,P<0.05)。ROC曲线显示,MiR-181b的AUC是0.694(95%CI:0.527～0.875),敏感度和特异度为56.8%和78.3%; MiR-132的AUC是0.627(95%CI:0.474～0.788),敏感度和特异度分别为52.4%和71.9%。Logistic回归分析显示,MiR-181b具有显著相对危险度(OR=2.346,95%CI:1.363～4.145,P=0.026)。结论 MiR-181b及MiR-132表达水平与精神分裂症发生和病情转归有一定的相关性,MiR-181b可作为预测精神分裂症发生的危险因素。
Abstract:
Objective To investigate microRNA-137(MiR-137),microRNA-181b(MiR-181b)and microRNA-132(MiR-132)expression levels inQiongxi area of schizophrenia patients with antipsychotic drug treatment process change and correlation.Methods Qiongxi area selected 386 cases of schizophrenia patients(case group)and 106 cases of healthy persons(control group)by real-time fluorescence quantitative PCR were used to detect the two groups of plasma MiR-137,MiR-181b and MiR-132 expression levels.104 cases of schizophrenia patients(observer group)with total score of Positive and Negative Syndrome Scale(PANSS)>70 were detected before treatment,treatment for 14 days,30 days of treatment and treatment for 50 days the expression levels of MiR-137,MiR-181b and MiR-132.By PANSS,global assessment scale(GAS)and severity of illness(SI)to evaluate the clinical symptoms and curative effect of different treatment stages of schizophrenia.Results Compared with the control group,the case group MiR-181b and MiR-132 wereup-regulated(Z=-3.315,P=0.001; Z=-2.036,P=0.038).The observer grouptreatment for 30 days and 50 days the expression of plasma MiR-181b and MiR-132 levels were significantly lower than before treatment and treatment for 14 days(t=8.382～12.651,P<0.05).The observer group treatment for 50 days the expression of plasma MiR-181b and MiR-132 levels than treatment for 30 dayssignificantly decreased(t=7.695～12.824,P<0.05).With the prolonging ofthe treatment time of patients in the observer group PANSS score and SI score were significantly decreased (t=8.711～10.273,P<0.01).With the prolonging of the treatment time of patients in the observer group GAS score was significantly increased(t=7.523～12.861,P<0.01).Correlation analysis showed that,with 30 days of treatment,treatment for 50 days in case group of MiR-181band MiR-132 levels downregulated were positively correlated with GAS score(r=0.537,P<0.05; r=0.492,P<0.05).50 days of treatment compared with before treatment,case group of MiR-181b and MiR-132 levels downregulated were negatively correlated with PANSS score(r=-0.503,P<0.05; r=-0.516,P<0.05).The ROC curve showed that the MiR-181b of AUC was 0.694(95%CI:0.527 to 0.875),the sensitivity and specificity were 56.8% and 78.3%。The MiR-132 ofAUC was 0.627(95%CI:0.474 to 0.788),the sensitivity and specificity were 52.4% and 71.9%.Logistic regression analysis showed that the MiR-181b has significant relative risk(OR=2.346,95%CI:1.363 to 4.145,P=0.026)。Conclusion MiR-181b and MiR-132 expression levels with schizophrenia incidence and disease outcome had some relevance,and MiR-181b can be used to predict risk factors of schizophrenic occurrence.

参考文献/References:

[1] Warnica W,Merico D,Costain G,et al.Copy number variable microRNA in schizophrenia and their neurodevelopmental gene targets[J].BiolPsychiatry,2015,77(2):158-166.
[2] Guan F,Zhang B,Yan T,et al.MIR137 gene and target gene CACNA1C of miR-137 contribute to schizophrenia susceptibility in Han Chinese[J].SchizophrRes,2014,152(1):97-104.
[3] Sun XY,Zhang J,Niu W,et al.A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia[J].Am J Med Genet B NeuropsychiatrGenet,2015,168B(3):170-178.
[4] Caputo V,Ciolfi A,Macri S,et al.The emerging role of MicroRNA in schizophrenia[J].CNS Neurol Disord Drug Targets,2015,14(2):208-221.
[5] Burmistrofa OA,Goltsov AY,Abramova LI,et al.MicroRNA in schizophrenia:genetic and expression analysis of miR-130b(22q11)[J].Biochemistry(Mosc),2007,72(5):578-582.
[6] Beveridge NJ,Tooney PA,Carroll AP,et al.Dysregulation of miRNA 181b in the temporal cortex in schizophrenia[J].Hum Mol Genet,2008,17(8):1156-1168.
[7] Ouyang YB,Lu Y,Yue S,et al.miR-181 targets multiple Bcl-2 familymembers and influences apoptosis and mitochondrial function in astrocyte[J].Mitochondrion,2012,12(2):213-219.
[8] Smrt RD,Szulwach KE,Pfeiffer RL,et al.microRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1[J].Stem Cells,2010,28(6):1060-1070.
[9] Szulwach KE,Li X,Smrt RD,et al.Cross talk between microRNA and epigenetic regulation in adult neurogenesis[J].J Cell Biol,2010,189(1):127-141.
[10] The Schizophrenia Psychiatric Genome-Wide Associati-on Study(GWAS)Consortium.Genome-wide association study identifies five new schizophrenia loci[J].Nat Genet,2011,43(10):969-976.
[11] Hansen KF,Sakamoto K,Wayman GA,et al.Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory[J].PLoS One,2010,5(11):e15497.
[12] Beveridge NJ,Gardiner E,Carroll AP,et al.Schizo-phrenia is associated with an increase in cortical microRNA biogenesis[J].Mol Psychiatry,2010,15(12):1176-1189.
[13] Yu HC,Wu J,Zhang HX,et al.Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophrenia patients[J].Prog Neuropsychopharmacol Biol Psychiatry,2015(63):23-29.
[14] Kocerha J,Faghihi MA,Lopez-Toledano MA,et al.MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction[J].Proc Natl Acad Sci USA,2009,106(9):3507-3512.
[15] Lett TA,Chakravarty MM,Felsky D,et al.The ge-nome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia[J].Mol Psychiatry,2013,18(4):443-450.
[16] Liu S,Yuan YB,Guan LL,et al.MiRNA-365 and miRNA-520c-3p respond to risperidone treatment in first-episode schizophrenia after a year remission[J].Chin Med J(Engl),2013,126(14):2676-2680.

相似文献/References:

[1]苏显都a,范长玲a,于 莉a,等.血浆及单核细胞中microRNA表达水平与精神分裂症患者的相关性研究[J].现代检验医学杂志,2017,32(02):45.[doi:10.3969/j.issn.1671-7414.2017.02.012]
　SU Xian-dua,FAN Chang-linga,YU Lia,et al.Association of Epression with the Level of MicroRNA in Plasma and Mononuclear Cells in Patients with Schizophrenia[J].Journal of Modern Laboratory Medicine,2017,32(04):45.[doi:10.3969/j.issn.1671-7414.2017.02.012]
[2]谭梅娟,李 靖.精神分裂症患者梅毒感染的流行病学调查[J].现代检验医学杂志,2018,33(04):125.[doi:10.3969/j.issn.1671-7414.2018.04.034]
　TAN Mei-juan,LI Jing.Study on Syphilis Infection among Inpatients with Schizophrenia[J].Journal of Modern Laboratory Medicine,2018,33(04):125.[doi:10.3969/j.issn.1671-7414.2018.04.034]
[3]段侠霞a,张 燕b,贺瑞峰a,等.儿童青少年精神分裂症与血清甲状腺激素水平的相关性分析[J].现代检验医学杂志,2018,33(06):80.[doi:10.3969/j.issn.1671-7414.2018.06.021]
　DUAN Xia-xiaa,ZHANG Yanb,HE Rui-fenga,et al.Correlation Analysis on Children and Adolescents with Schizophrenia and Serum Thyroid Hormones[J].Journal of Modern Laboratory Medicine,2018,33(04):80.[doi:10.3969/j.issn.1671-7414.2018.06.021]
[4]平军娇a,高永双b,邓顺顺a,等.广东省中山地区汉族精神类疾病患者药物基因型及代谢表型分布研究[J].现代检验医学杂志,2019,34(03):15.[doi:10.3969/j.issn.1671-7414.2019.03.004]
　PING Jun-jiaoa,GAO Yong-shuangb,DENGShun-shuna,et al.Research on Characteristics of Drug Genotypesand Metabolic Phenotypes in Chinese Han Patients with Severe MentalIllness in Zhongshan Area of Guangdong Province[J].Journal of Modern Laboratory Medicine,2019,34(04):15.[doi:10.3969/j.issn.1671-7414.2019.03.004]

备注/Memo

备注/Memo:
基金项目:海南省医药卫生科研基金项目(15A200002)。
作者简介:苏显都(1988-),男,本科,检验师,从事临床检验诊断学研究,E-mial:adgbn129@126.com。
更新日期/Last Update: 2016-08-10